Fused thiazole derivatives as kinase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 277/82 (2006.01) A61K 31/425 (2006.01) A61K 31/5377 (2006.01) A61K 31/55 (2006.01) C07D 513/04 (2006.01)

Patent

CA 2607426

A series of 5,6-dihydro-l,3-benzothiazol-7(4H)-one derivatives, and analogues thereof, which are substituted in the 2-position by an optionally substituted morpholin-4-yl moiety, being selective inhibitors of PD kinase enzymes, are accordingly of b.enefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.

L'invention concerne une série de dérivés de la 5,6-dihydro-l,3-benzothiazol-7(4H)-one, et leurs analogues, substitués en position 2 par un groupe morpholin-4-yle éventuellement substitué, agissant comme des inhibiteurs sélectifs des enzymes PD kinases, et utiles en médecine, par exemple pour le traitement de maladies inflammatoires, auto-immunes, cardiovasculaires, neurodégénératrices, métaboliques, oncologiques, nociceptives ou ophtalmiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Fused thiazole derivatives as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fused thiazole derivatives as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused thiazole derivatives as kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1851985

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.